此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

EXCEL-Punjabi: A Culturally Tailored Exercise Oncology Pilot Feasibility Intervention (EXCEL-Punjabi)

2026年6月8日 更新者:University of Calgary

EXCEL-Punjabi: Tailored Exercise Oncology for the South Asian Population

The goal of this pilot feasibility study is to explore the feasibility and exploratory effects of a culturally-tailored exercise oncology intervention in Punjabi-speaking individuals of South Asian heritage and their support persons. The main questions it aims to answer are:

  1. What is the feasibility and acceptability of the EXCEL-Punjabi intervention?
  2. What are the exploratory effects (i.e., psychosocial and physical changes) before and after program delivery?

Participants will take part in a 12-week exercise oncology intervention consisting of twice weekly hour long multimodal circuit-based exercise sessions. They will also complete questionnaires and functional fitness assessments pre- and post- intervention.

研究概览

地位

完全的

条件

研究类型

介入性

注册 (实际的)

12

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Alberta
      • Calgary、Alberta、加拿大、T2N 1N4
        • Genesis Centre Calgary

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

是的

描述

Inclusion Criteria:

  • Punjabi-speaking
  • Self-identified as being of South Asian heritage
  • over the age of 18
  • pre-, post-, or currently receiving cancer treatment or a support person of an individual living with and beyond cancer
  • cleared to participate in, at minimum, mild intensity exercise by a Clinical Exercise Physiologist
  • Able to provide informed consent

Exclusion Criteria:

  • under the age of 18
  • not cleared to exercise by a Clinical Exercise Physiologist

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:EXCEL-Punjabi
Culturally Tailored Exercise Oncology Intervention
Culturally Tailored Exercise Oncology Intervention

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Measurement Completion
大体时间:Baseline to the end of the intervention (12 weeks)
Participants who completed all pre- and post- questionnaires and functional assessments
Baseline to the end of the intervention (12 weeks)

次要结果测量

结果测量
措施说明
大体时间
Referrals
大体时间:Baseline to end of intervention (12 weeks)
Number of participants referred to intervention
Baseline to end of intervention (12 weeks)
Consented
大体时间:Recruitment to end of intervention (12 weeks)
Number of participants who consented to participate in the intervention
Recruitment to end of intervention (12 weeks)
Enrolled
大体时间:Baseline (week 0)
Number of participants who enrolled (i.e. completed baseline assessments)
Baseline (week 0)
Attendance
大体时间:Baseline to end of intervention (12 weeks)
Intervention Attendance
Baseline to end of intervention (12 weeks)
Adverse Events
大体时间:Baseline to end of intervention (12 weeks)
Using the standardized Common Terminology Criteria for Adverse Events Version 6.0
Baseline to end of intervention (12 weeks)
Time Required to Deliver and Implement Intervention
大体时间:From recruitment to end of intervention (12 weeks)
Time requirement to deliver intervention
From recruitment to end of intervention (12 weeks)
Physical Activity Level
大体时间:Baseline to end of intervention (12 weeks)
The Godin Leisure Time Exercise Questionnaire is used to determine subjective levels of physical activity in each participant. Participants report how many times per week they partake in mild, moderate, and/or strenuous exercise. Higher scores indicate a more physically active lifestyle.
Baseline to end of intervention (12 weeks)
Cancer related symptoms
大体时间:Baseline to end of intervention (12 weeks)
Change in Edmonton Symptom Assessment Scale - revised: cancer. Scale is from 0-10, where 0 means the symptom is absent and 10 means the worst possible severity of the symptom is being experienced.
Baseline to end of intervention (12 weeks)
Health Related Quality of Life
大体时间:Baseline to end of intervention (12 weeks)
Change in EuroQual - 5Dimensions (EQ-5D) tool - first section is a questionnaire; last section uses a scale from 0-100, where 0 means the worst health imaginable and 100 means the best health imaginable.
Baseline to end of intervention (12 weeks)
Fatigue
大体时间:Baseline to end of intervention (12 weeks)
Change in Functional Assessment of Chronic Illness Therapy - Fatigue subscale - scale is from 0-4, where 0 means "not at all" and 4 means "very much".
Baseline to end of intervention (12 weeks)
Cancer Related Quality of Life
大体时间:Baseline to end of intervention (12 weeks)
A 5-point Likert scale (0 = not at all, to 4 = very much) to track wellbeing over the course of the cancer journey.
Baseline to end of intervention (12 weeks)
Exercise Barriers Self-Efficacy
大体时间:Baseline to end of intervention (12 weeks)
Exercise barriers and facilitators questionnaire
Baseline to end of intervention (12 weeks)
Cognition
大体时间:Baseline to end of intervention (12 weeks)
Cancer related cognition using the Functional Assessment of Cancer Therapy - Cognition questionnaire. A 37-item, self-report questionnaire used to evaluate how cancer patients perceive their own cognitive abilities
Baseline to end of intervention (12 weeks)
Aerobic Capacity
大体时间:Baseline to end of intervention (12 weeks)
In-person participants will be assessed on change in 6-minute walk test (m) results
Baseline to end of intervention (12 weeks)
Aerobic Capacity
大体时间:Baseline to end of intervention (12 weeks)
Online participants will be assessed with change in the 2-minute step test (number of steps) results.
Baseline to end of intervention (12 weeks)
Lower body strength
大体时间:Baseline to end of intervention (12 weeks)
Change in sit-to-stand (number of repetitions in 30 seconds)
Baseline to end of intervention (12 weeks)
Upper extremity flexibility
大体时间:Baseline to end of intervention (12 weeks)
Change in active shoulder flexion range of motion (degrees)
Baseline to end of intervention (12 weeks)
Balance
大体时间:Baseline to end of intervention (12 weeks)
Change in one legged stance test (seconds)
Baseline to end of intervention (12 weeks)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年7月1日

初级完成 (实际的)

2025年12月12日

研究完成 (实际的)

2025年12月12日

研究注册日期

首次提交

2026年5月11日

首先提交符合 QC 标准的

2026年6月8日

首次发布 (实际的)

2026年6月11日

研究记录更新

最后更新发布 (实际的)

2026年6月11日

上次提交的符合 QC 标准的更新

2026年6月8日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • HREBA.CC-25-0150

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

IPD 计划说明

Aggregate and participant-level results are reported within publications, but there is no formal plan for external IPD sharing. With a small sample size from a specific cultural group, there may be risk of re-identification.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅